Adjuvant Capital
Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
15
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Adjuvant Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- AH
Abrar Haque
Investor · General Business & Management
EmailPhone - GB
Giulia Balconi
Life Sciences Venture Capital · Other
EmailPhone - GC
Gerard Cunningham
Operating Partner · Operations
EmailPhone - GR
Glenn Rockman
Founder and Managing Partner · Other
EmailPhone - KA
Kabeer Aziz
Partner · General Business & Management
EmailPhone - MS
Mark Sullivan
Venture Partner · General Business & Management
EmailPhone
Showing 6 of 8 verified contacts
Top roles at Adjuvant Capital
7 distinct titles indexed · top 7 shown.
- 1founder and managing partner
- 1investor
- 1life sciences venture capital
- 1member of social impact committee
- 1operating partner
- 1partner
- 1venture partner
Sign up to unlock all 8 contacts at Adjuvant Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Adjuvant Capital
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.